A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00280358|
Recruitment Status : Completed
First Posted : January 23, 2006
Last Update Posted : March 7, 2008
|Condition or disease||Intervention/treatment||Phase|
|Healthy||Drug: Fluticasone Propionate Drug: Formoterol Fumarate||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||30 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Actual Study Completion Date :||December 2005|
- Levels of study medication in blood and urine.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00280358
|United States, Kansas|
|Lenexa, Kansas, United States, 66219|